Atlas Trials

Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis

Clinical trial NCT02943447 · TERMINATED

Trial details

NCT number
NCT02943447
Sponsor
Gilead Sciences
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Biliary Cholangitis
Start date
2016-12-01
Primary completion
2019-09-04
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.